The Edison report values KZA at $2 at this current time in this...

The Edison report values KZA at $2 at this current time in this current state... this will go up on further good news.

And we are now so shiny, credible and polished that world class oncology groups have done their research and are spending their hard earned money on research with Kazia’s GDC-0084 as they can see the company has a plan for the coming years.

This stock has rerated from mid low thirty cents to fifty its been consolidating for another leg up.

We have multiple readouts due in the next two months and some big news management is clearly excited for but not finalised as yet and I think this may be a company changing item...

I have been following KZA for 5 years and invested in it for 4 years and continue to acquire more periodically... and there has never been this much buzz with third parties now investing in the GDC-0084 compound adding value, more exciting news around Cantrixil, we have restructured, rebranded and have a excellent science team and management team... we are considered the new breed of science co offering mid tier services and disrupting old business models.